Keizai Doyukai will start mass inoculation for employees of small and medium-sized enterprises and venture companies from the 21st of this month in cooperation with a company that rents conference rooms.
According to the announcement, Keizai Doyukai will start mass inoculation of the new coronavirus vaccine for small and medium-sized enterprises and venture companies with less than 1000 employees in cooperation with companies in Tokyo that rent conference rooms.
Approximately 43,000 employees and their families from nearly 120 companies to which the members belong will be vaccinated.
In addition to the venue, cooperating companies will secure doctors and nurses, while companies wishing to receive vaccination will be required to bear part of the operating costs.
At a press conference, Keizai Doyukai's secretary-general, Sakurada, said, "The final trump card for the convergence of infection is vaccines, and speed is the game. We would like to promote inoculation to startups with small companies."
Takateru Kawano, president of TKP, a cooperating company, said, "I think that small and medium-sized enterprises and venture companies have the same desire to inoculate employees. I would like to provide venues and other facilities to help the Japanese economy recover." Was there.